Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study

Mohammed Baqur S. Al‐Shuhaib, Hayder O. Hashim, Jafar M. B. Al‐Shuhaib